Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans

• Published in: Diabetes (New York, N.Y.) Vol. 47; no. 10; pp. 1555 - 1561
• Main Authors: C Weyer, P A Tataranni, S Snitker, E Danforth, Jr, E Ravussin
• Format: Journal Article
• Language: English
• Published: United States American Diabetes Association 01.10.1998
• Subjects: Adrenergic beta-Agonists - pharmacology; Adult; Blood Glucose - metabolism; Body Composition; Body Weight; Dioxoles - adverse effects; Dioxoles - blood; Dioxoles - pharmacology; Double-Blind Method; Energy Metabolism; Fatty Acids, Nonesterified - blood; Glucose Clamp Technique; Humans; Insulin - blood; Insulin - pharmacology; Leptin; Lipid Metabolism; Male; Oxidation-Reduction; Proteins - metabolism

Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans. C Weyer , P A Tataranni , S Snitker , E Danforth, Jr and E Ravussin Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney...